Attachment 2 - Price Schedule.xlsx
XLSX spreadsheet 22 KB Posted
- Attached to
- H265--CONTROLLED ENVIRONMENT TESTING Federal contract opportunity
- Solicitation number
- 36C25925Q0509
About this file
The file is a Price Schedule Excel spreadsheet for a Controlled Environment Testing contract with the Department of Veterans Affairs Veterans Health Administration (VA VHA). The contract covers comprehensive testing services for two pharmacy locations in Montana (Fort Harrison and Billings) over four contract periods from August 2025 to July 2030.
The pricing schedule details multiple line items for specialized testing services, including viable sampling (air and surface), non-viable particle count (NVPC), smoke video testing, HEPA filter assessments, and differential pressure measurements across various pharmacy rooms such as hazardous and non-hazardous buffer rooms, ante rooms, and clean air flow workstations. Additional services include development of USP reports, parts procurement, labor for repairs, and travel to both facility locations. The contract is structured with consistent line items repeated across four annual contract periods, with each period maintaining the same scope of testing and associated services.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Attachment B - DOL 2015-5399 MT Lewis Clark rv24 12.22.24.pdf | ||
| Attachment A - DOL 2015-5389 rv25 Yellowstone MT 5.20.25.pdf | ||
| 36C25925Q0509.docx | DOCX document | |
| Attachment 3 - LOS 852.219-75 - SERVICES.docx | DOCX document | |
| Attachment 1 - SOW -Controlled Environment Testing.doc | DOC document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Table 1
| Price Schedule | |||||||
| CONTRACT LINE ITEM NUMBER (CLIN) | DESCRIPTION | ROOM | Unit | UNIT PRICE | ESTIMATED QTY | EXTENDED PRICE | TOTAL |
| FORT HARRISON MONTANA-PHARMACY | |||||||
| 0001 | C-SCA: Viable Sampling (air & surface), ACPH, Differential Pressure |
| FHM17 | EA | 2 | |||
| 0002 | REVISIT- C-SCA | ||||
| FHM17 | EA | 1 | |||
| 0003 | CACI: Viable Sampling (air & surface, main chamber & passthrough), non-viable particle count (NVPC), Smoke Video | FHM17 | EA | 2 | |
| 0004 | REVISIT - CACI | FHM17 | EA | 1 | |
| 0005 | SCA: Viable Sampling (air &surface) | FHM169 | EA | 2 | |
| 0006 | REVISIT - SCA | FHM169 | EA | 1 | |
| 0007 | LAFW: Viable Sampling (air & surface), NVPC, Smoke Video | FHM169 | EA | 2 | |
| 0008 | REVISIT - LAFW | FHM169 | EA | 1 | |
| 0009 | Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170 | EA | 2 | |
| 0010 | REVISIT - Hazardous Buffer Room | FHM170 | EA | 1 | |
| 0011 | Hazardous Buffer Room: HEPA | FHM170 | EA | 2 | |
| 0012 | REVISIT - Hazardous Buffer Room: HEPA | FHM170 | EA | 1 | |
| 0013 | HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM170 | EA | 2 | |
| 0014 | REVISIT - HEPA pass-through | FHM170 | EA | 1 | |
| 0015 | Hazardous Buffer Room BSC: Viable Sampling (air & surface), NVPC, Smoke Video | FHM170 | EA | 2 | |
| 0016 | REVISIT - Hazardous Buffer Room BSC | FHM170 | EA | 1 | |
| 0017 | Hazardous Ante Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170B | EA | 2 | |
| 0018 | REVISIT - Hazardous Ante Room | FHM170B | EA | 1 | |
| 0019 | Hazardous Ante Room HEPA | FHM170B | EA | 2 | |
| 0020 | REVISIT - Hazardous Ante Room HEPA | FHM170B | EA | 1 | |
| 0021 | Non-Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM171 | EA | 2 | |
| 0022 | REVISIT - Non-Hazardous Buffer Room | FHM171 | EA | 1 | |
| 0023 | Non-Hazardous Buffer Room HEPA | FHM171 | EA | 2 | |
| 0024 | REVISIT - Non-Hazardous Buffer Room HEPA | FHM171 | EA | 1 | |
| 0025 | Non-Hazardous Buffer Room HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM171 | EA | 2 | |
| 0026 | REVISIT - Non-Hazardous Buffer Room HEPA pass-through | FHM171 | EA | 1 | |
| 0027 | Non-Hazardous Buffer Room LAFW: Viable Sampling (2 air & 2 surface), NVPC, Smoke Video | FHM171 | EA | 2 | |
| 0028 | REVISIT - Non-Hazardous Buffer Room LAFW | FHM171 | EA | 1 | |
| 0029 | Control Plates | EA | 2 | ||
| 0030 | REVISIT - Control Plates | EA | 1 | ||
| Billings Montana Pharmacy | |||||
| 0031 | SCA: Viable Sampling (air & surface) | EA | 2 | ||
| 0032 | REVISIT - SCA | EA | 1 | ||
| 0033 | CAI: Viable Sampling (2 air & 2 surface),NVPC, Smoke Video | EA | 2 | ||
| 0034 | REVISIT - CAI | EA | 1 | ||
| 0035 | Control Plates | EA | 2 | ||
| 0036 | REVISIT - Control Plates | EA | 1 | ||
| TRAVEL AND DELIVERABLES | |||||
| 0037 | Development of USP Reports for Pharmacy | EA | 4 | ||
| 0038 | Parts | JB | 1 | ||
| 0039 | Labor Cost for Repairs | HR | 1 | ||
| 0040 | Travel to visit both Facilities- (all travel costs included) | EA | 2 | ||
| 0041 | REVISIT - Travel to Billings Only-(all travel costs included) | EA | 1 | ||
| 0042 | REVISIT - Travel to Fort Harrison Only (all travel costs included) | EA | 1 | ||
| BASE Contract Period 8/1/2025-7/31/2026 | TOTAL | ||||
| FORT HARRISON MONTANA-PHARMACY | |||||
| 1001 | C-SCA: Viable Sampling (air & surface), ACPH, Differential Pressure |
| FHM17 | EA | 2 | ||||
| 1002 | REVISIT- C-SCA | |||||
| FHM17 | EA | 1 | ||||
| 1003 | CACI: Viable Sampling (air & surface, main chamber & passthrough), non-viable particle count (NVPC), Smoke Video | FHM17 | EA | 2 | ||
| 1004 | REVISIT - CACI | FHM17 | EA | 1 | ||
| 1005 | SCA: Viable Sampling (air &surface) | FHM169 | EA | 2 | ||
| 1006 | REVISIT - SCA | FHM169 | EA | 1 | ||
| 1007 | LAFW: Viable Sampling (air & surface), NVPC, Smoke Video | FHM169 | EA | 2 | ||
| 1008 | REVISIT - LAFW | FHM169 | EA | 1 | ||
| 1009 | Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170 | EA | 2 | ||
| 1010 | REVISIT - Hazardous Buffer Room | FHM170 | EA | 1 | ||
| 1011 | Hazardous Buffer Room: HEPA | FHM170 | EA | 2 | ||
| 1012 | REVISIT - Hazardous Buffer Room: HEPA | FHM170 | EA | 1 | ||
| 1013 | HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM170 | EA | 2 | ||
| 1014 | REVISIT - HEPA pass-through | FHM170 | EA | 1 | ||
| 1015 | Hazardous Buffer Room BSC: Viable Sampling (air & surface), NVPC, Smoke Video | FHM170 | EA | 2 | ||
| 1016 | REVISIT - Hazardous Buffer Room BSC | FHM170 | EA | 1 | ||
| 1017 | Hazardous Ante Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170B | EA | 2 | ||
| 1018 | REVISIT - Hazardous Ante Room | FHM170B | EA | 1 | ||
| 1019 | Hazardous Ante Room HEPA | FHM170B | EA | 2 | ||
| 1020 | REVISIT - Hazardous Ante Room HEPA | FHM170B | EA | 1 | ||
| 1021 | Non-Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM171 | EA | 2 | ||
| 1022 | REVISIT - Non-Hazardous Buffer Room | FHM171 | EA | 1 | ||
| 1023 | Non-Hazardous Buffer Room HEPA | FHM171 | EA | 2 | ||
| 1024 | REVISIT - Non-Hazardous Buffer Room HEPA | FHM171 | EA | 1 | ||
| 1025 | Non-Hazardous Buffer Room HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM171 | EA | 2 | ||
| 1026 | REVISIT - Non-Hazardous Buffer Room HEPA pass-through | FHM171 | EA | 1 | ||
| 1027 | Non-Hazardous Buffer Room LAFW: Viable Sampling (2 air & 2 surface), NVPC, Smoke Video | FHM171 | EA | 2 | ||
| 1028 | REVISIT - Non-Hazardous Buffer Room LAFW | FHM171 | EA | 1 | ||
| 1029 | Control Plates | EA | 2 | |||
| 1030 | REVISIT - Control Plates | EA | 1 | |||
| Billings Montana Pharmacy | ||||||
| 1031 | SCA: Viable Sampling (air & surface) | EA | 2 | |||
| 1032 | REVISIT - SCA | EA | 1 | |||
| 1033 | CAI: Viable Sampling (2 air & 2 surface),NVPC, Smoke Video | EA | 2 | |||
| 1034 | REVISIT - CAI | EA | 1 | |||
| 1035 | Control Plates | EA | 2 | |||
| 1036 | REVISIT - Control Plates | EA | 1 | |||
| TRAVEL AND DELIVERABLES | ||||||
| 1037 | Development of USP Reports for Pharmacy | EA | 4 | |||
| 1038 | Parts | JB | 1 | |||
| 1039 | Labor Cost for Repairs | HR | 1 | |||
| 1040 | Travel to visit both Facilities | |||||
| (all associated travel costs included) | EA | 2 | ||||
| 1041 | REVISIT - Travel to Billings Only | |||||
| (all associated travel costs included) | EA | 1 | ||||
| 1042 | REVISIT - Travel to Fort Harrison Only) | |||||
| (all associated travel costs included) | EA | 1 | ||||
| Contract Period 1 - 8/1/2026-7/31/2027 | TOTAL | |||||
| FORT HARRISON MONTANA-PHARMACY | ||||||
| 2001 | C-SCA: Viable Sampling (air & surface), ACPH, Differential Pressure |
| FHM17 | EA | 2 | ||||
| 2002 | REVISIT- C-SCA | |||||
| FHM17 | EA | 1 | ||||
| 2003 | CACI: Viable Sampling (air & surface, main chamber & passthrough), non-viable particle count (NVPC), Smoke Video | FHM17 | EA | 2 | ||
| 2004 | REVISIT - CACI | FHM17 | EA | 1 | ||
| 2005 | SCA: Viable Sampling (air &surface) | FHM169 | EA | 2 | ||
| 2006 | REVISIT - SCA | FHM169 | EA | 1 | ||
| 2007 | LAFW: Viable Sampling (air & surface), NVPC, Smoke Video | FHM169 | EA | 2 | ||
| 2008 | REVISIT - LAFW | FHM169 | EA | 1 | ||
| 2009 | Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170 | EA | 2 | ||
| 2010 | REVISIT - Hazardous Buffer Room | FHM170 | EA | 1 | ||
| 2011 | Hazardous Buffer Room: HEPA | FHM170 | EA | 2 | ||
| 2012 | REVISIT - Hazardous Buffer Room: HEPA | FHM170 | EA | 1 | ||
| 2013 | HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM170 | EA | 2 | ||
| 2014 | REVISIT - HEPA pass-through | FHM170 | EA | 1 | ||
| 2015 | Hazardous Buffer Room BSC: Viable Sampling (air & surface), NVPC, Smoke Video | FHM170 | EA | 2 | ||
| 2016 | REVISIT - Hazardous Buffer Room BSC | FHM170 | EA | 1 | ||
| 2017 | Hazardous Ante Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170B | EA | 2 | ||
| 2018 | REVISIT - Hazardous Ante Room | FHM170B | EA | 1 | ||
| 2019 | Hazardous Ante Room HEPA | FHM170B | EA | 2 | ||
| 2020 | REVISIT - Hazardous Ante Room HEPA | FHM170B | EA | 1 | ||
| 2021 | Non-Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM171 | EA | 2 | ||
| 2022 | REVISIT - Non-Hazardous Buffer Room | FHM171 | EA | 1 | ||
| 2023 | Non-Hazardous Buffer Room HEPA | FHM171 | EA | 2 | ||
| 2024 | REVISIT - Non-Hazardous Buffer Room HEPA | FHM171 | EA | 1 | ||
| 2025 | Non-Hazardous Buffer Room HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM171 | EA | 2 | ||
| 2026 | REVISIT - Non-Hazardous Buffer Room HEPA pass-through | FHM171 | EA | 1 | ||
| 2027 | Non-Hazardous Buffer Room LAFW: Viable Sampling (2 air & 2 surface), NVPC, Smoke Video | FHM171 | EA | 2 | ||
| 2028 | REVISIT - Non-Hazardous Buffer Room LAFW | FHM171 | EA | 1 | ||
| 2029 | Control Plates | EA | 2 | |||
| 2030 | REVISIT - Control Plates | EA | 1 | |||
| Billings Montana Pharmacy | ||||||
| 2031 | SCA: Viable Sampling (air & surface) | EA | 2 | |||
| 2032 | REVISIT - SCA | EA | 1 | |||
| 2033 | CAI: Viable Sampling (2 air & 2 surface),NVPC, Smoke Video | EA | 2 | |||
| 2034 | REVISIT - CAI | EA | 1 | |||
| 2035 | Control Plates | EA | 2 | |||
| 2036 | REVISIT - Control Plates | EA | 1 | |||
| TRAVEL AND DELIVERABLES | ||||||
| 2037 | Development of USP Reports for Pharmacy | EA | 4 | |||
| 2038 | Parts | JB | 1 | |||
| 2039 | Labor Cost for Repairs | HR | 1 | |||
| 2040 | Travel to visit both Facilities | |||||
| (all associated travel costs included) | EA | 2 | ||||
| 2041 | REVISIT - Travel to Billings Only | |||||
| (all associated travel costs included) | EA | 1 | ||||
| 2042 | REVISIT - Travel to Fort Harrison Only) | |||||
| (all associated travel costs included) | EA | 1 | ||||
| Contract Period 2 - 8/1/2027-7/31/2028 | TOTAL | |||||
| FORT HARRISON MONTANA-PHARMACY | ||||||
| 3001 | C-SCA: Viable Sampling (air & surface), ACPH, Differential Pressure |
| FHM17 | EA | 2 | ||||
| 3002 | REVISIT- C-SCA | |||||
| FHM17 | EA | 1 | ||||
| 3003 | CACI: Viable Sampling (air & surface, main chamber & passthrough), non-viable particle count (NVPC), Smoke Video | FHM17 | EA | 2 | ||
| 3004 | REVISIT - CACI | FHM17 | EA | 1 | ||
| 3005 | SCA: Viable Sampling (air &surface) | FHM169 | EA | 2 | ||
| 3006 | REVISIT - SCA | FHM169 | EA | 1 | ||
| 3007 | LAFW: Viable Sampling (air & surface), NVPC, Smoke Video | FHM169 | EA | 2 | ||
| 3008 | REVISIT - LAFW | FHM169 | EA | 1 | ||
| 3009 | Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170 | EA | 2 | ||
| 3010 | REVISIT - Hazardous Buffer Room | FHM170 | EA | 1 | ||
| 3011 | Hazardous Buffer Room: HEPA | FHM170 | EA | 2 | ||
| 3012 | REVISIT - Hazardous Buffer Room: HEPA | FHM170 | EA | 1 | ||
| 3013 | HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM170 | EA | 2 | ||
| 3014 | REVISIT - HEPA pass-through | FHM170 | EA | 1 | ||
| 3015 | Hazardous Buffer Room BSC: Viable Sampling (air & surface), NVPC, Smoke Video | FHM170 | EA | 2 | ||
| 3016 | REVISIT - Hazardous Buffer Room BSC | FHM170 | EA | 1 | ||
| 3017 | Hazardous Ante Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170B | EA | 2 | ||
| 3018 | REVISIT - Hazardous Ante Room | FHM170B | EA | 1 | ||
| 3019 | Hazardous Ante Room HEPA | FHM170B | EA | 2 | ||
| 3020 | REVISIT - Hazardous Ante Room HEPA | FHM170B | EA | 1 | ||
| 3021 | Non-Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM171 | EA | 2 | ||
| 3022 | REVISIT - Non-Hazardous Buffer Room | FHM171 | EA | 1 | ||
| 3023 | Non-Hazardous Buffer Room HEPA | FHM171 | EA | 2 | ||
| 3024 | REVISIT - Non-Hazardous Buffer Room HEPA | FHM171 | EA | 1 | ||
| 3025 | Non-Hazardous Buffer Room HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM171 | EA | 2 | ||
| 3026 | REVISIT - Non-Hazardous Buffer Room HEPA pass-through | FHM171 | EA | 1 | ||
| 3027 | Non-Hazardous Buffer Room LAFW: Viable Sampling (2 air & 2 surface), NVPC, Smoke Video | FHM171 | EA | 2 | ||
| 3028 | REVISIT - Non-Hazardous Buffer Room LAFW | FHM171 | EA | 1 | ||
| 3029 | Control Plates | EA | 2 | |||
| 3030 | REVISIT - Control Plates | EA | 1 | |||
| Billings Montana Pharmacy | ||||||
| 3031 | SCA: Viable Sampling (air & surface) | EA | 2 | |||
| 3032 | REVISIT - SCA | EA | 1 | |||
| 3033 | CAI: Viable Sampling (2 air & 2 surface),NVPC, Smoke Video | EA | 2 | |||
| 3034 | REVISIT - CAI | EA | 1 | |||
| 3035 | Control Plates | EA | 2 | |||
| 3036 | REVISIT - Control Plates | EA | 1 | |||
| TRAVEL AND DELIVERABLES | ||||||
| 3037 | Development of USP Reports for Pharmacy | EA | 4 | |||
| 3038 | Parts | JB | 1 | |||
| 3039 | Labor Cost for Repairs | HR | 1 | |||
| 3040 | Travel to visit both Facilities | |||||
| (all associated travel costs included) | EA | 2 | ||||
| 3041 | REVISIT - Travel to Billings Only | |||||
| (all associated travel costs included) | EA | 1 | ||||
| 3042 | REVISIT - Travel to Fort Harrison Only) | |||||
| (all associated travel costs included) | EA | 1 | ||||
| Contract Period 3 - 8/1/2028-7/31/2029 | TOTAL | |||||
| FORT HARRISON MONTANA-PHARMACY | ||||||
| 4001 | C-SCA: Viable Sampling (air & surface), ACPH, Differential Pressure |
| FHM17 | EA | 2 | ||||
| 4002 | REVISIT- C-SCA | |||||
| FHM17 | EA | 1 | ||||
| 4003 | CACI: Viable Sampling (air & surface, main chamber & passthrough), non-viable particle count (NVPC), Smoke Video | FHM17 | EA | 2 | ||
| 4004 | REVISIT - CACI | FHM17 | EA | 1 | ||
| 4005 | SCA: Viable Sampling (air &surface) | FHM169 | EA | 2 | ||
| 4006 | REVISIT - SCA | FHM169 | EA | 1 | ||
| 4007 | LAFW: Viable Sampling (air & surface), NVPC, Smoke Video | FHM169 | EA | 2 | ||
| 4008 | REVISIT - LAFW | FHM169 | EA | 1 | ||
| 4009 | Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170 | EA | 2 | ||
| 4010 | REVISIT - Hazardous Buffer Room | FHM170 | EA | 1 | ||
| 4011 | Hazardous Buffer Room: HEPA | FHM170 | EA | 2 | ||
| 4012 | REVISIT - Hazardous Buffer Room: HEPA | FHM170 | EA | 1 | ||
| 4013 | HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM170 | EA | 2 | ||
| 4014 | REVISIT - HEPA pass-through | FHM170 | EA | 1 | ||
| 4015 | Hazardous Buffer Room BSC: Viable Sampling (air & surface), NVPC, Smoke Video | FHM170 | EA | 2 | ||
| 4016 | REVISIT - Hazardous Buffer Room BSC | FHM170 | EA | 1 | ||
| 4017 | Hazardous Ante Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM170B | EA | 2 | ||
| 4018 | REVISIT - Hazardous Ante Room | FHM170B | EA | 1 | ||
| 4019 | Hazardous Ante Room HEPA | FHM170B | EA | 2 | ||
| 4020 | REVISIT - Hazardous Ante Room HEPA | FHM170B | EA | 1 | ||
| 4021 | Non-Hazardous Buffer Room: Viable Sampling (1 air & 2 surface), NVPC, ACPH, Differential Pressure | FHM171 | EA | 2 | ||
| 4022 | REVISIT - Non-Hazardous Buffer Room | FHM171 | EA | 1 | ||
| 4023 | Non-Hazardous Buffer Room HEPA | FHM171 | EA | 2 | ||
| 4024 | REVISIT - Non-Hazardous Buffer Room HEPA | FHM171 | EA | 1 | ||
| 4025 | Non-Hazardous Buffer Room HEPA pass-through: Viable Sampling (air & surface), HEPA | FHM171 | EA | 2 | ||
| 4026 | REVISIT - Non-Hazardous Buffer Room HEPA pass-through | FHM171 | EA | 1 | ||
| 4027 | Non-Hazardous Buffer Room LAFW: Viable Sampling (2 air & 2 surface), NVPC, Smoke Video | FHM171 | EA | 2 | ||
| 4028 | REVISIT - Non-Hazardous Buffer Room LAFW | FHM171 | EA | 1 | ||
| 4029 | Control Plates | EA | 2 | |||
| 4030 | REVISIT - Control Plates | EA | 1 | |||
| Billings Montana Pharmacy | ||||||
| 4031 | SCA: Viable Sampling (air & surface) | EA | 2 | |||
| 4032 | REVISIT - SCA | EA | 1 | |||
| 4033 | CAI: Viable Sampling (2 air & 2 surface),NVPC, Smoke Video | EA | 2 | |||
| 4034 | REVISIT - CAI | EA | 1 | |||
| 4035 | Control Plates | EA | 2 | |||
| 4036 | REVISIT - Control Plates | EA | 1 | |||
| TRAVEL AND DELIVERABLES | ||||||
| 4037 | Development of USP Reports for Pharmacy | EA | 4 | |||
| 4038 | Parts | JB | 1 | |||
| 4039 | Labor Cost for Repairs | HR | 1 | |||
| 4040 | Travel to visit both Facilities | |||||
| (all associated travel costs included) | EA | 2 | ||||
| 4041 | REVISIT - Travel to Billings Only | |||||
| (all associated travel costs included) | EA | 1 | ||||
| 4042 | REVISIT - Travel to Fort Harrison Only) | |||||
| (all associated travel costs included) | EA | 1 | ||||
| Contract Period 4 - 8/1/2029-7/31/2030 | TOTAL | |||||
| TOTAL CONTRACT |
File details come from the government source that posted it. Updated .